title: The basics of heart failure management: are they being ignored?
abstract: BACKGROUND
  Advances have been made in the medical management of congestive heart failure. However, there is concern that these changes may not be transmitted to the heart failure population in the community. Other impediments to improved prognosis, such as failure to apply non-pharmacological strategies and poor patient comprehension may also be prevalent in the community.
  
  
  OBJECTIVE
  The purpose of this study was to assess physician practice and patient knowledge in a heart failure population admitted to a University Hospital in Ireland.
  
  
  METHODS
  Patients admitted with a primary diagnosis of heart failure were studied. Estimation of ejection fraction was used to subdivide the population into heart failure with impaired and normal systolic function. Patients' course in hospital was noted with reference to management by cardiology or internal medicine, use of angiotensin-converting enzyme inhibition therapy and digoxin and application of dietary and rehabilitative services. Patient knowledge was assessed by questionnaire.
  
  
  RESULTS
  Eighty patients were included in this study. Two-thirds of the population had impaired systolic function. The majority of patients were managed by internal medicine physicians, and this population was older and more likely to have normal systolic function. Prescription of converting enzyme inhibitor therapy was more frequently used in cardiology-managed patients (96 vs. 70%, P<0.05). Neither group applied dietary or rehabilitative advice to a significant level. Patient comprehension was poor, especially with regard to understanding of medicine and the value of weight measurement.
  
  
  CONCLUSIONS
  The above data demonstrate a lack of use of rehabilitative and dietary services and poor patient knowledge. These deficiencies may play a role in determining outlook and may impede the expected improvement in prognosis that has been witnessed in large randomised studies.
authors.affiliation: St Vincent's Hospital Cardiomyopathy Research Group, St Vincent's Hospital, Dublin, Ireland.
authors.forename: M
authors.initials: M
authors.lastname: Horan
authors.forename: F
authors.initials: F
authors.lastname: Barrett
authors.forename: M
authors.initials: M
authors.lastname: Mulqueen
authors.forename: B
authors.initials: B
authors.lastname: Maurer
authors.forename: P
authors.initials: P
authors.lastname: Quigley
authors.forename: K M
authors.initials: KM
authors.lastname: McDonald
mesh_terms: D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D004077:Digoxin / Q000627:therapeutic use; D004363:Drug Utilization; D005260:Female; D006333:Heart Failure / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007494:Ireland; D008297:Male; D010353:Patient Education as Topic; D010818:Practice Patterns, Physicians'; D011379:Prognosis
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D004077:Digoxin